Your session is about to expire
← Back to Search
Behavioral Intervention
Animal-Assisted Therapy for Aphasia (PATD Trial)
N/A
Recruiting
Led By Sharon M Antonucci, Ph.D.
Research Sponsored by Albert Einstein Healthcare Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Clinical diagnosis of aphasia acquired as the result of cerebro-vascular accident (CVA)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate arm: baseline, 6-weeks post baseline, 3 month follow-up; delayed arm: 2 baselines (6 weeks apart), 6-weeks post 2nd baseline, 3 month follow-up
Awards & highlights
PATD Trial Summary
This trial studies how a PATD program can help people with aphasia (language loss due to stroke) gain confidence and social engagement, enabling them to live better lives.
Who is the study for?
This trial is for English-speaking adults with aphasia, a language impairment usually from stroke. Participants must understand the study, be willing and able to take part in activities, and live within an hour's drive of the research sites in Elkins Park or Philadelphia, PA.Check my eligibility
What is being tested?
The study tests the Persons with Aphasia Training Dogs Program (PATD), which uses dog training techniques to improve confidence and social engagement for people living with aphasia.See study design
What are the potential side effects?
Since this program involves animal-assisted therapy rather than medication, traditional side effects are not expected. However, participants may experience emotional fatigue or stress during training sessions.
PATD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have speech difficulties due to a stroke.
PATD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate arm: baseline, 6-weeks post baseline, 3 month follow-up; delayed arm: 2 baselines (6 weeks apart), 6-weeks post 2nd baseline, 3 month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate arm: baseline, 6-weeks post baseline, 3 month follow-up; delayed arm: 2 baselines (6 weeks apart), 6-weeks post 2nd baseline, 3 month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change on Assessment of Living with Aphasia (ALA, Kagan et al., 2010)
Change on PI-adapted version of Pet Partners Animal-handler Evaluation.
Secondary outcome measures
Change on Behavioural Assessment of Dysexecutive Syndrome (Wilson et al., 1996)
Cerebrovascular accident
PATD Trial Design
2Treatment groups
Experimental Treatment
Group I: ImmediateExperimental Treatment1 Intervention
Participants in this group will begin the training protocol immediately (within 1 week) after baseline pre-training evaluation is completed.
Group II: DelayedExperimental Treatment1 Intervention
Participants in the delayed arm will participate in two pre-training evaluations, one immediately upon enrollment and one at the end of the delay period immediately before beginning training
Find a Location
Who is running the clinical trial?
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,777 Total Patients Enrolled
3 Trials studying Aphasia
64 Patients Enrolled for Aphasia
Albert Einstein Healthcare NetworkLead Sponsor
64 Previous Clinical Trials
868,692 Total Patients Enrolled
2 Trials studying Aphasia
130 Patients Enrolled for Aphasia
Sharon M Antonucci, Ph.D.Principal InvestigatorAEHN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I understand what is required of me in this research.I have speech difficulties due to a stroke.I am willing and able to follow the study's requirements.I have a neurological condition that is not a stroke.
Research Study Groups:
This trial has the following groups:- Group 1: Immediate
- Group 2: Delayed
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities to join this research endeavor at present?
"According to records available on clinicaltrials.gov, this research project is actively seeking participants and was recently updated on March 31st 2023. The trial commenced recruiting on the 30th of March in that same year."
Answered by AI
To what capacity is this clinical trial accommodating participants?
"Affirmative. The clinical trial registry states that the study began recruitment on March 30th 2023 and is currently looking for 20 participants from a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger